Denali Therapeutics Inc.
DNLI- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001714899
In the last 90 days, Denali Therapeutics Inc. insiders filed 0 open-market purchases and 4 sales; 294 institutions reported holding it in 13F filings for Q2 2026, worth $4.00B in total; no superinvestor holds it.
13F holders, Q3 2021
Institutional positions in Denali Therapeutics Inc. as of Sep 30, 2021. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 214
- +6 vs. Q2 2021
- Shares held
- 84.8M
- +4.69M (+5.8%) vs. Q2 2021
- Total value
- $4.28B
- −$2.00B (−31.9%) vs. Q2 2021
- New holders
- 37
- 81 more added
- Sold out
- 31
- 65 more reduced
2 institutions that held it in Q2 2021 haven't filed for Q3 2021 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q2 2021: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting DNLI on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 294 | $4.00B |
| Q1 2026 | 269 | $2.82B |
| Q4 2025 | 250 | $2.50B |
| Q3 2025 | 240 | $1.97B |
| Q2 2025 | 231 | $1.93B |
| Q1 2025 | 222 | $1.85B |
| Q4 2024 | 224 | $2.61B |
| Q3 2024 | 217 | $3.69B |
| Q2 2024 | 203 | $2.88B |
| Q1 2024 | 211 | $2.51B |
| Q4 2023 | 209 | $2.47B |
| Q3 2023 | 195 | $2.24B |
| Q2 2023 | 203 | $3.18B |
| Q1 2023 | 202 | $2.49B |
| Q4 2022 | 199 | $2.94B |
| Q3 2022 | 200 | $2.84B |
| Q2 2022 | 188 | $2.73B |
| Q1 2022 | 190 | $2.79B |
| Q4 2021 | 213 | $3.80B |
| Q3 2021 | 214 | $4.28B |
| Q2 2021 | 210 | $6.32B |
| Q1 2021 | 218 | $4.60B |
Institutions, Q3 2021
Shares, value and share of portfolio for each institution holding Denali Therapeutics Inc.; share changes are against Q2 2021.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Bamco Inc | 1,127,919 | $56.9M | 0.13% | −127,305−10.1% | Reduced |
| Geode Capital Management, LLC | 1,607,394 | $81.1M | 0.01% | +90,373+6.0% | Added |
| Casdin Capital, LLC | 1,700,000 | $85.8M | 2.14% | +90,000+5.6% | Added |
| Credit Suisse AG | 1,982,473 | $100.0M | 0.08% | +15,965+0.8% | Added |
| FMR LLC | 2,675,749 | $135.0M | 0.01% | +6,666+0.2% | Added |
| Flagship Pioneering Inc. | 2,730,263 | $137.7M | 1.44% | 00.0% | Unchanged |
| State Street Corp | 2,798,134 | $141.2M | 0.01% | +477,674+20.6% | Added |
| Gilder Gagnon Howe & Co LLC | 2,802,994 | $141.4M | 0.73% | −32,739−1.2% | Reduced |
| Price T Rowe Associates Inc | 4,757,965 | $240.0M | 0.02% | −145,487−3.0% | Reduced |
| Temasek Holdings (Private) Ltd | 5,369,487 | $270.9M | 0.95% | +959,030+21.7% | Added |
| BlackRock Inc. | 7,560,837 | $381.4M | 0.01% | +524,796+7.5% | Added |
| Crestline Management, LP | 7,705,039 | $388.7M | 36.97% | −430,442−5.3% | Reduced |
| Vanguard Group Inc | 8,168,483 | $412.1M | 0.01% | +524,353+6.9% | Added |
| Baillie Gifford & Co | 15,009,816 | $757.2M | 0.40% | −137,797−0.9% | Reduced |
| Nomura Asset Management Co Ltd | 0 | $0 | 0.00% | −7,210−100.0% | Sold out |
| Euclidean Capital LLC | 0 | $0 | 0.00% | −323,749−100.0% | Sold out |
| Lisanti Capital Growth, LLC | 0 | $0 | 0.00% | −98,130−100.0% | Sold out |
| JGP Global Gestao de Recursos Ltda. | 0 | $0 | 0.00% | −91,760−100.0% | Sold out |
| Avidity Partners Management LP | 0 | $0 | 0.00% | −86,100−100.0% | Sold out |
| Stenahm Asset Managment Ltd | 0 | $0 | 0.00% | −45,000−100.0% | Sold out |
| ExodusPoint Capital Management, LP | 0 | $0 | 0.00% | −20,959−100.0% | Sold out |
| Public Employees Retirement System of Ohio | 0 | $0 | 0.00% | −20,201−100.0% | Sold out |
| Connor, Clark & Lunn Investment Management Ltd. | 0 | $0 | 0.00% | −19,993−100.0% | Sold out |
| Hillsdale Investment Management Inc. | 0 | $0 | 0.00% | −17,200−100.0% | Sold out |
| Jacobs Levy Equity Management, Inc | 0 | $0 | 0.00% | −7,679−100.0% | Sold out |
| Bellecapital International Ltd. | 0 | $0 | 0.00% | −7,644−100.0% | Sold out |
| Engineers Gate Manager LP | 0 | $0 | 0.00% | −6,030−100.0% | Sold out |
| JustInvest LLC | 0 | $0 | 0.00% | −6,012−100.0% | Sold out |
| Man Group plc | 0 | $0 | 0.00% | −5,464−100.0% | Sold out |
| Quantitative Systematic Strategies LLC | 0 | $0 | 0.00% | −4,301−100.0% | Sold out |
| Sargent Investment Group, LLC | 0 | $0 | 0.00% | −3,817−100.0% | Sold out |
| LPL Financial LLC | 0 | $0 | 0.00% | −3,266−100.0% | Sold out |
| Aigen Investment Management, LP | 0 | $0 | 0.00% | −3,243−100.0% | Sold out |
| Grace Capital | 0 | $0 | 0.00% | −3,000−100.0% | Sold out |
| Fernwood Investment Management, LLC | 0 | $0 | 0.00% | −3,000−100.0% | Sold out |
| Plancorp, LLC | 0 | $0 | 0.00% | −2,900−100.0% | Sold out |
| Connable Office Inc | 0 | $0 | 0.00% | −2,699−100.0% | Sold out |
| Toroso Investments, LLC | 0 | $0 | 0.00% | −2,576−100.0% | Sold out |
| Islay Capital Management, LLC | 0 | $0 | 0.00% | −2,013−100.0% | Sold out |
| Advisory Services Network, LLC | 0 | $0 | 0.00% | −1,922−100.0% | Sold out |
| Group One Trading, L.P. | 0 | $0 | 0.00% | −1,193−100.0% | Sold out |
| First Manhattan Co | 0 | $0 | 0.00% | −200−100.0% | Sold out |
| Princeton Global Asset Management LLC | 0 | $0 | 0.00% | −80−100.0% | Sold out |
| Bellwether Advisors, LLC | 0 | $0 | 0.00% | −86−100.0% | Sold out |
| AdvisorNet Financial, Inc | 0 | $0 | 0.00% | −50−100.0% | Sold out |
| Pictet Asset Management Ltd | – | – | – | – | Not filed |
| Hoover Financial Advisors, Inc. | – | – | – | – | Not filed |